AFP and hepatocellular carcinoma: Additionally, we conducted more rigorous statistical testing and model validation as well as included AFP, a widely employed clinical marker for hepatocellular carcinoma, in our study to confirm its prognostic value in patients with HCC-NCL, thus distinguishing our risk stratification system from those of previous studies (Dasari et al. 2020).